GEVELOT SA (ALGEV.PA) Fundamental Analysis & Valuation

EPA:ALGEV • FR0000033888

Current stock price

174 EUR
+1 (+0.58%)
Last:

This ALGEV.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALGEV.PA Profitability Analysis

1.1 Basic Checks

  • ALGEV had positive earnings in the past year.
  • ALGEV had a positive operating cash flow in the past year.
  • ALGEV had positive earnings in each of the past 5 years.
  • Of the past 5 years ALGEV 4 years had a positive operating cash flow.
ALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

  • ALGEV has a worse Return On Assets (0.13%) than 69.81% of its industry peers.
  • Looking at the Return On Equity, with a value of 0.16%, ALGEV is doing worse than 68.87% of the companies in the same industry.
  • ALGEV has a worse Return On Invested Capital (0.48%) than 79.25% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ALGEV is significantly below the industry average of 8.58%.
Industry RankSector Rank
ROA 0.13%
ROE 0.16%
ROIC 0.48%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ALGEV.PA Yearly ROA, ROE, ROICALGEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

  • The Profit Margin of ALGEV (0.23%) is worse than 69.81% of its industry peers.
  • In the last couple of years the Profit Margin of ALGEV has declined.
  • With a Operating Margin value of 0.97%, ALGEV is not doing good in the industry: 80.19% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of ALGEV has declined.
  • The Gross Margin of ALGEV (59.17%) is better than 83.02% of its industry peers.
  • ALGEV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.97%
PM (TTM) 0.23%
GM 59.17%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
ALGEV.PA Yearly Profit, Operating, Gross MarginsALGEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. ALGEV.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALGEV is destroying value.
  • ALGEV has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ALGEV has less shares outstanding
  • The debt/assets ratio for ALGEV is higher compared to a year ago.
ALGEV.PA Yearly Shares OutstandingALGEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALGEV.PA Yearly Total Debt VS Total AssetsALGEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • ALGEV has an Altman-Z score of 3.65. This indicates that ALGEV is financially healthy and has little risk of bankruptcy at the moment.
  • ALGEV's Altman-Z score of 3.65 is amongst the best of the industry. ALGEV outperforms 80.19% of its industry peers.
  • The Debt to FCF ratio of ALGEV is 2.95, which is a good value as it means it would take ALGEV, 2.95 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 2.95, ALGEV is doing good in the industry, outperforming 75.47% of the companies in the same industry.
  • A Debt/Equity ratio of 0.04 indicates that ALGEV is not too dependend on debt financing.
  • ALGEV has a better Debt to Equity ratio (0.04) than 88.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.95
Altman-Z 3.65
ROIC/WACC0.06
WACC7.81%
ALGEV.PA Yearly LT Debt VS Equity VS FCFALGEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • ALGEV has a Current Ratio of 5.07. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
  • ALGEV's Current ratio of 5.07 is amongst the best of the industry. ALGEV outperforms 97.17% of its industry peers.
  • ALGEV has a Quick Ratio of 3.68. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of ALGEV (3.68) is better than 96.23% of its industry peers.
Industry RankSector Rank
Current Ratio 5.07
Quick Ratio 3.68
ALGEV.PA Yearly Current Assets VS Current LiabilitesALGEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ALGEV.PA Growth Analysis

3.1 Past

  • ALGEV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.89%.
  • Measured over the past years, ALGEV shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -17.19% on average per year.
  • Looking at the last year, ALGEV shows a small growth in Revenue. The Revenue has grown by 2.81% in the last year.
  • ALGEV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.90% yearly.
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEV.PA Yearly Revenue VS EstimatesALGEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALGEV.PA Yearly EPS VS EstimatesALGEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

2

4. ALGEV.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 386.67, the valuation of ALGEV can be described as expensive.
  • 72.64% of the companies in the same industry are cheaper than ALGEV, based on the Price/Earnings ratio.
  • ALGEV's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.78.
  • The Price/Forward Earnings ratio is 12.86, which indicates a correct valuation of ALGEV.
  • 66.04% of the companies in the same industry are more expensive than ALGEV, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of ALGEV to the average of the S&P500 Index (23.54), we can say ALGEV is valued slightly cheaper.
Industry RankSector Rank
PE 386.67
Fwd PE 12.86
ALGEV.PA Price Earnings VS Forward Price EarningsALGEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • ALGEV's Enterprise Value to EBITDA is on the same level as the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as ALGEV.
Industry RankSector Rank
P/FCF 40.13
EV/EBITDA 12.51
ALGEV.PA Per share dataALGEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALGEV does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)108.99
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ALGEV.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.86%, ALGEV has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 1.64, ALGEV pays a better dividend. On top of this ALGEV pays more dividend than 82.08% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, ALGEV pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.86%

5.2 History

  • On average, the dividend of ALGEV grows each year by 21.15%, which is quite nice.
Dividend Growth(5Y)21.15%
Div Incr Years0
Div Non Decr Years5
ALGEV.PA Yearly Dividends per shareALGEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

  • 1132.65% of the earnings are spent on dividend by ALGEV. This is not a sustainable payout ratio.
  • ALGEV's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP1132.65%
EPS Next 2YN/A
EPS Next 3YN/A
ALGEV.PA Yearly Income VS Free CF VS DividendALGEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M
ALGEV.PA Dividend Payout.ALGEV.PA Dividend Payout, showing the Payout Ratio.ALGEV.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ALGEV.PA Fundamentals: All Metrics, Ratios and Statistics

GEVELOT SA

EPA:ALGEV (4/9/2026, 7:00:00 PM)

174

+1 (+0.58%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-30
Earnings (Next)04-09
Inst Owners1.21%
Inst Owner ChangeN/A
Ins Owners7.72%
Ins Owner ChangeN/A
Market Cap130.50M
Revenue(TTM)148.53M
Net Income(TTM)340.00K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.86%
Yearly Dividend5.17
Dividend Growth(5Y)21.15%
DP1132.65%
Div Incr Years0
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 386.67
Fwd PE 12.86
P/S 0.88
P/FCF 40.13
P/OCF 16.56
P/B 0.62
P/tB 0.63
EV/EBITDA 12.51
EPS(TTM)0.45
EY0.26%
EPS(NY)13.53
Fwd EY7.78%
FCF(TTM)4.34
FCFY2.49%
OCF(TTM)10.51
OCFY6.04%
SpS198.04
BVpS281.9
TBVpS277.87
PEG (NY)108.99
PEG (5Y)N/A
Graham Number53.42
Profitability
Industry RankSector Rank
ROA 0.13%
ROE 0.16%
ROCE 0.64%
ROIC 0.48%
ROICexc 0.57%
ROICexgc 0.58%
OM 0.97%
PM (TTM) 0.23%
GM 59.17%
FCFM 2.19%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ROICexc(3y)3.55%
ROICexc(5y)3.63%
ROICexgc(3y)3.61%
ROICexgc(5y)3.72%
ROCE(3y)3.99%
ROCE(5y)3.37%
ROICexgc growth 3Y-45.56%
ROICexgc growth 5Y-35.96%
ROICexc growth 3Y-45.2%
ROICexc growth 5Y-34.4%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 2.95
Debt/EBITDA 0.99
Cap/Depr 66.07%
Cap/Sales 3.12%
Interest Coverage 250
Cash Conversion 93.23%
Profit Quality 956.47%
Current Ratio 5.07
Quick Ratio 3.68
Altman-Z 3.65
F-Score5
WACC7.81%
ROIC/WACC0.06
Cap/Depr(3y)120.29%
Cap/Depr(5y)120.78%
Cap/Sales(3y)5.31%
Cap/Sales(5y)6.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-84.81%
EBIT growth 3Y-30.96%
EBIT growth 5Y-22.68%
EBIT Next Year84.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y140.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y261.56%
OCF growth 3Y-10.1%
OCF growth 5Y-0.33%

GEVELOT SA / ALGEV.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of GEVELOT SA (ALGEV.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALGEV.PA.


What is the valuation status for ALGEV stock?

ChartMill assigns a valuation rating of 2 / 10 to GEVELOT SA (ALGEV.PA). This can be considered as Overvalued.


Can you provide the profitability details for GEVELOT SA?

GEVELOT SA (ALGEV.PA) has a profitability rating of 3 / 10.


What is the financial health of GEVELOT SA (ALGEV.PA) stock?

The financial health rating of GEVELOT SA (ALGEV.PA) is 8 / 10.


Can you provide the dividend sustainability for ALGEV stock?

The dividend rating of GEVELOT SA (ALGEV.PA) is 5 / 10 and the dividend payout ratio is 1132.65%.